{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:19:50Z","timestamp":1766524790291,"version":"3.48.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-025-01628-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:30:16Z","timestamp":1762950616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact of bisphosphonate treatment in reducing fragility fractures in Jordan: Insights from a developing country"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-9304","authenticated-orcid":false,"given":"Moh\u2019d S.","family":"Dawod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-5861","authenticated-orcid":false,"given":"Mohammad N.","family":"Alswerki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6358-4700","authenticated-orcid":false,"given":"Ahmad F.","family":"Alelaumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8205-6041","authenticated-orcid":false,"given":"Batool M.","family":"Alquabe\u2019h","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0167-6362","authenticated-orcid":false,"given":"Ayham","family":"Dahooh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3789-2439","authenticated-orcid":false,"given":"Diala","family":"AlDerbashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Al Baidhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3111-4473","authenticated-orcid":false,"given":"Ibrahim","family":"Shawaqfeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4071-9907","authenticated-orcid":false,"given":"Almothana","family":"Matalqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"6","key":"1628_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/J.MCNA.2021.05.016","volume":"105","author":"AK Anam","year":"2021","unstructured":"Anam AK, Insogna K (2021) Update on osteoporosis screening and management. Med Clin North Am 105(6):1117\u20131134. https:\/\/doi.org\/10.1016\/J.MCNA.2021.05.016","journal-title":"Med Clin North Am"},{"key":"1628_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS242115772","author":"IV Zhivodernikov","year":"2023","unstructured":"Zhivodernikov IV, Kirichenko TV, Markina YV, Postnov AY, Markin AM (2023) Molecular and cellular mechanisms of osteoporosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS242115772","journal-title":"Int J Mol Sci"},{"key":"1628_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.injury.2017.08.029","volume":"48","author":"M Smith","year":"2017","unstructured":"Smith M, Giannoudis PV (2017) Fragility fractures: A complex interaction of the health care system- the patient and the bone: can we do better? Injury 48:S1\u2013S3. https:\/\/doi.org\/10.1016\/j.injury.2017.08.029","journal-title":"Injury"},{"issue":"1","key":"1628_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.CDTM.2015.02.006","volume":"1","author":"M Ji","year":"2015","unstructured":"Ji M, Yu Q (2015) Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 1(1):9\u201313. https:\/\/doi.org\/10.1016\/J.CDTM.2015.02.006","journal-title":"Chronic Dis Transl Med"},{"issue":"10","key":"1628_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/S40618-019-01041-6","volume":"42","author":"J Liu","year":"2019","unstructured":"Liu J, Curtis EM, Cooper C, Harvey NC (2019) State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest 42(10):1149\u20131164. https:\/\/doi.org\/10.1007\/S40618-019-01041-6","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1628_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/S00198-012-2240-2","volume":"24","author":"F Borgstr\u00f6m","year":"2013","unstructured":"Borgstr\u00f6m F et al (2013) The international costs and utilities related to osteoporotic fractures study (ICUROS) - quality of life during the first 4 months after fracture. Osteoporos Int 24(3):811\u2013823. https:\/\/doi.org\/10.1007\/S00198-012-2240-2","journal-title":"Osteoporos Int"},{"issue":"12","key":"1628_CR7","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/S00198-013-2408-4","volume":"24","author":"F Guillemin","year":"2013","unstructured":"Guillemin F et al (2013) Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int 24(12):3001\u20133010. https:\/\/doi.org\/10.1007\/S00198-013-2408-4","journal-title":"Osteoporos Int"},{"issue":"3","key":"1628_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5312\/WJO.V7.I3.171","volume":"7","author":"P Pisani","year":"2016","unstructured":"Pisani P et al (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7(3):171\u2013181. https:\/\/doi.org\/10.5312\/WJO.V7.I3.171","journal-title":"World J Orthop"},{"issue":"2","key":"1628_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/BOR.0000000000000365","volume":"29","author":"JA Cauley","year":"2017","unstructured":"Cauley JA (2017) Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol 29(2):150\u2013156. https:\/\/doi.org\/10.1097\/BOR.0000000000000365","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"1628_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/S00256-012-1549-4\/METRICS","volume":"42","author":"H Bischoff-Ferrari","year":"2013","unstructured":"Bischoff-Ferrari H (Feb.2013) Fragility fractures: The future epidemic and its challenges. Skeletal Radiol 42(2):161\u2013163. https:\/\/doi.org\/10.1007\/S00256-012-1549-4\/METRICS","journal-title":"Skeletal Radiol"},{"key":"1628_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/TCRM.S72456","volume":"10","author":"AS Nazrun","year":"2014","unstructured":"Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN (Nov.2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 10:937\u2013948. https:\/\/doi.org\/10.2147\/TCRM.S72456","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"1628_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cger.2014.01.001","volume":"30","author":"SM Friedman","year":"2014","unstructured":"Friedman SM, Mendelson DA (2014) Epidemiology of fragility fractures. Clin Geriatr Med 30(2):175\u2013181. https:\/\/doi.org\/10.1016\/j.cger.2014.01.001","journal-title":"Clin Geriatr Med"},{"key":"1628_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/J.BONR.2016.07.005","volume":"5","author":"D Weycker","year":"2016","unstructured":"Weycker D, Li X, Barron R, Bornheimer R, Chandler D (2016) Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes. Bone Rep 5:186\u2013191. https:\/\/doi.org\/10.1016\/J.BONR.2016.07.005","journal-title":"Bone Rep"},{"issue":"1\u20132","key":"1628_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11657-013-0126-3\/TABLES\/3","volume":"8","author":"L Hansen","year":"2013","unstructured":"Hansen L, Mathiesen AS, Vestergaard P, Ehlers LH, Petersen KD (Dec.2013) A health economic analysis of osteoporotic fractures: Who carries the burden? Arch Osteoporos 8(1\u20132):1\u20139. https:\/\/doi.org\/10.1007\/S11657-013-0126-3\/TABLES\/3","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1628_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FPC.0B013E328335729C","volume":"21","author":"L Gong","year":"2011","unstructured":"Gong L, Altman RB, Klein TE (2011) Bisphosphonates pathway. Pharmacogenet Genomics 21(1):50\u201353. https:\/\/doi.org\/10.1097\/FPC.0B013E328335729C","journal-title":"Pharmacogenet Genomics"},{"issue":"27","key":"1628_CR16","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.2174\/138161210793563635","volume":"16","author":"AJ Roelofs","year":"2010","unstructured":"Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 16(27):2950\u20132960. https:\/\/doi.org\/10.2174\/138161210793563635","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1628_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/JOIM.12873","volume":"285","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon M (2019) Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med 285(4):381\u2013394. https:\/\/doi.org\/10.1111\/JOIM.12873","journal-title":"J Intern Med"},{"key":"1628_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.BONE.2016.05.013","volume":"89","author":"J Sanderson","year":"2016","unstructured":"Sanderson J et al (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: a systematic review and network meta-analysis. Bone 89:52\u201358. https:\/\/doi.org\/10.1016\/J.BONE.2016.05.013","journal-title":"Bone"},{"issue":"1","key":"1628_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/S00198-006-0274-Z\/FIGURES\/5","volume":"18","author":"SL Silverman","year":"2007","unstructured":"Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R (Jan.2007) Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study. Osteoporos Int 18(1):25\u201334. https:\/\/doi.org\/10.1007\/S00198-006-0274-Z\/FIGURES\/5","journal-title":"Osteoporos Int"},{"issue":"10","key":"1628_CR20","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1185\/03007990903172894","volume":"25","author":"S Boonen","year":"2009","unstructured":"Boonen S (2009) Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective. Curr Med Res Opin 25(10):2335\u20132341. https:\/\/doi.org\/10.1185\/03007990903172894","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"1628_CR21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1517\/14656566.7.11.1457","volume":"7","author":"CC Kennedy","year":"2006","unstructured":"Kennedy CC, Papaioannou A, Adachi JD (2006) Treating osteoporosis: economic aspects of bisphosphonate therapy. Expert Opin Pharmacother 7(11):1457\u20131467. https:\/\/doi.org\/10.1517\/14656566.7.11.1457","journal-title":"Expert Opin Pharmacother"},{"key":"1628_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.BONR.2019.100216","volume":"11","author":"F Al Anouti","year":"2019","unstructured":"Al Anouti F, Taha Z, Shamim S, Khalaf K, Al Kaabi L, Alsafar H (2019) An insight into the paradigms of osteoporosis: from genetics to biomechanics. Bone Rep 11:100216. https:\/\/doi.org\/10.1016\/J.BONR.2019.100216","journal-title":"Bone Rep"},{"issue":"2","key":"1628_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/20479700.2019.1658159","volume":"14","author":"Y Jalghoum","year":"2021","unstructured":"Jalghoum Y, Tahtamouni A, Khasawneh S, Al-Madadha A (2021) Challenges to healthcare information systems development: the case of Jordan. Int J Healthc Manag 14(2):447\u2013455. https:\/\/doi.org\/10.1080\/20479700.2019.1658159","journal-title":"Int J Healthc Manag"},{"issue":"9","key":"1628_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/MLR.0B013E318054689F","volume":"45","author":"SM Cadarette","year":"2007","unstructured":"Cadarette SM, Gignac MAM, Jaglal SB, Beaton DE, Hawker GA (2007) Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing. Med Care 45(9):896\u2013901. https:\/\/doi.org\/10.1097\/MLR.0B013E318054689F","journal-title":"Med Care"},{"issue":"7624","key":"1628_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/BMJ.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806. https:\/\/doi.org\/10.1136\/BMJ.39335.541782.AD","journal-title":"BMJ"},{"issue":"5","key":"1628_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1185\/030079906X100276","volume":"22","author":"J Iwamoto","year":"2006","unstructured":"Iwamoto J, Takeda T, Sato Y (2006) Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Curr Med Res Opin 22(5):919\u2013928. https:\/\/doi.org\/10.1185\/030079906X100276","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"1628_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1345\/APH.1C246","volume":"37","author":"SF Eichner","year":"2003","unstructured":"Eichner SF, Lloyd KB, Timpe EM (2003) Comparing therapies for postmenopausal osteoporosis prevention and treatment. Ann Pharmacother 37(5):711\u2013724. https:\/\/doi.org\/10.1345\/APH.1C246","journal-title":"Ann Pharmacother"},{"issue":"9041","key":"1628_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348(9041):1535\u20131541. https:\/\/doi.org\/10.1016\/S0140-6736(96)07088-2","journal-title":"Lancet"},{"issue":"18","key":"1628_CR29","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMOA067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u20131822. https:\/\/doi.org\/10.1056\/NEJMOA067312","journal-title":"N Engl J Med"},{"issue":"4","key":"1628_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/01.BOR.0000166384.80777.0D","volume":"17","author":"E Dennison","year":"2005","unstructured":"Dennison E, Cole Z, Cooper C (2005) Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol 17(4):456\u2013461. https:\/\/doi.org\/10.1097\/01.BOR.0000166384.80777.0D","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"1628_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/S00198-016-3894-Y","volume":"28","author":"NCW Harvey","year":"2017","unstructured":"Harvey NCW et al (2017) Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 28(5):1507\u20131529. https:\/\/doi.org\/10.1007\/S00198-016-3894-Y","journal-title":"Osteoporos Int"},{"issue":"4","key":"1628_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/JBMR.2393","volume":"30","author":"D Bliuc","year":"2015","unstructured":"Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30(4):637\u2013646. https:\/\/doi.org\/10.1002\/JBMR.2393","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1628_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/J.JAMDA.2012.07.011","volume":"13","author":"M Martinez-Reig","year":"2012","unstructured":"Martinez-Reig M, Ahmad L, Duque G (2012) The orthogeriatrics model of care: systematic review of predictors of institutionalization and mortality in post-hip fracture patients and evidence for interventions. J Am Med Dir Assoc 13(9):770\u2013777. https:\/\/doi.org\/10.1016\/J.JAMDA.2012.07.011","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"1628_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.injury.2020.10.037","volume":"52","author":"ZT Sharfman","year":"2021","unstructured":"Sharfman ZT et al (2021) Increased morbidity and mortality in elderly patients with lower extremity trauma and associated injuries: a review of 420,066 patients from the national trauma database. Injury 52(4):757\u2013766. https:\/\/doi.org\/10.1016\/j.injury.2020.10.037","journal-title":"Injury"},{"issue":"7","key":"1628_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/J.MAYOCP.2024.01.011","volume":"99","author":"AA Khan","year":"2024","unstructured":"Khan AA et al (2024) Osteoporotic fractures: diagnosis, evaluation, and significance from the International Working Group on DXA best practices. Mayo Clin Proc 99(7):1127\u20131141. https:\/\/doi.org\/10.1016\/J.MAYOCP.2024.01.011","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"1628_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrendo.2014.55","volume":"10","author":"NB Watts","year":"2014","unstructured":"Watts NB (2014) Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Nat Rev Endocrinol 10(7):412\u2013422. https:\/\/doi.org\/10.1038\/nrendo.2014.55","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1628_CR37","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/S00198-017-3911-9","volume":"28","author":"C Kerr","year":"2017","unstructured":"Kerr C et al (2017) The importance of physical function to people with osteoporosis. Osteoporos Int 28(5):1597\u20131607. https:\/\/doi.org\/10.1007\/S00198-017-3911-9","journal-title":"Osteoporos Int"},{"issue":"7","key":"1628_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/JWH.2013.4611","volume":"23","author":"JM Kling","year":"2014","unstructured":"Kling JM, Clarke BL, Sandhu NP (2014) Osteoporosis prevention, screening, and treatment: a review. J Womens Health 23(7):563\u2013572. https:\/\/doi.org\/10.1089\/JWH.2013.4611","journal-title":"J Womens Health"},{"issue":"6","key":"1628_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/S11914-015-0289-5","volume":"13","author":"ML Gourlay","year":"2015","unstructured":"Gourlay ML, Overman RA, Ensrud KE (2015) Bone density screening and re-screening in postmenopausal women and older men. Curr Osteoporos Rep 13(6):390\u2013398. https:\/\/doi.org\/10.1007\/S11914-015-0289-5","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"1628_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-137-6-200209170-00014\/ASSET\/IMAGES\/14TT2.JPG","volume":"137","author":"AO Berg","year":"2002","unstructured":"Berg AO et al (Sep.2002) Screening for osteoporosis in postmenopausal women: Recommendations and rationale. Ann Intern Med 137(6):526\u2013528. https:\/\/doi.org\/10.7326\/0003-4819-137-6-200209170-00014\/ASSET\/IMAGES\/14TT2.JPG","journal-title":"Ann Intern Med"},{"issue":"4","key":"1628_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.amepre.2009.01.013","volume":"36","author":"LS Lim","year":"2009","unstructured":"Lim LS, Hoeksema LJ, Sherin K (2009) Screening for osteoporosis in the adult U.S. population. ACPM position statement on preventive practice. Am J Prev Med 36(4):366\u2013375. https:\/\/doi.org\/10.1016\/j.amepre.2009.01.013","journal-title":"Am J Prev Med"},{"issue":"14","key":"1628_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH19148803","volume":"19","author":"R Saadeh","year":"2022","unstructured":"Saadeh R et al (2022) Osteoporosis among postmenopausal women in Jordan: a national cross-sectional study. Int J Environ Res Public Health 19(14):8803. https:\/\/doi.org\/10.3390\/IJERPH19148803","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"1628_CR43","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/PHN.13379","volume":"41","author":"MHA Khurmah","year":"2024","unstructured":"Khurmah MHA, Alkhatatbeh MJ, Alshogran OY, Alarda HM (2024) Prevalence and risk factors of osteopenia and osteoporosis among postmenopausal women: a cross-sectional study from Jordan. Public Health Nurs 41(5):996\u20131005. https:\/\/doi.org\/10.1111\/PHN.13379","journal-title":"Public Health Nurs"},{"issue":"1","key":"1628_CR44","doi-asserted-by":"publisher","DOI":"10.1089\/BIORES.2016.0045","volume":"6","author":"D Hyassat","year":"2017","unstructured":"Hyassat D, Alyan T, Jaddou H, Ajlouni KM (2017) Prevalence and risk factors of osteoporosis among Jordanian postmenopausal women attending the National Center for Diabetes, Endocrinology and Genetics in Jordan. Biores Open Access 6(1):85. https:\/\/doi.org\/10.1089\/BIORES.2016.0045","journal-title":"Biores Open Access"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01628-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:17:16Z","timestamp":1766524636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01628-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1628"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01628-y","relation":{},"ISSN":["1862-3514"],"issn-type":[{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the JUH Institutional Review Board (IRB approval No. 2023\/14\/2). Informed consent was obtained from all participants prior to inclusion in the study. All data were handled confidentially, with no identifying information retained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Moh'd S. Dawod, Mohammad N. Alswerki, Ahmad F. Alelaumi, Batool M. Alquabe\u2019h, Ayham Dahooh, Diala AlDerbashi, Rasa Al Baidhani, Ibrahim Shawaqfeh, and Almothana Matalqa declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"142"}}